₹2095.35
0.82%
Low
Day's Volatility:3.19%
High
2.37%
41.44%
Low
52 Weeks Volatility:61.90%
High
20.46%
Returns % | |
1 Month Return | 8.31 % |
3 Month Return | -14.41 % |
1 Year Return | 68.44 % |
Market Stats | |
Previous Close | ₹2,101.75 |
Open | ₹2,122.00 |
Volume | 1.02L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹35,604.91Cr |
based on 4 analysts
Based on 4 analysts offering long term price targets for Glaxosmithkline Pharmaceuticals Ltd. An average target of ₹2141.25
Source: S&P Global Market Intelligence
Organisation | Glaxosmithkline Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals aims to achieve double-digit growth over the next three to five years. The company manufactures vaccines, medications, and consumer products, including Horlicks brand packaged food and beverage powders.
GlaxoSmithKline Pharmaceuticals Ltd's High P/E Ratio Justified by Strong Earnings Growth - 14 Apr, 2024
Despite a significantly higher than average P/E ratio of 60.3x, GlaxoSmithKline Pharmaceuticals Ltd's positive outlook and expected 41% increase in EPS for the coming year justifies the high valuation.
Fundamentals of Glaxosmithkline Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, GLAXO stock has moved up by 8.3%
Best in 1 Year
In the last 1 year, GLAXO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Up
Retail Investor have increased holdings from 13.43% to 13.62% in Mar 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 2.92% to 3.48% in Mar 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 4.50% to 4.51% in Mar 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.00% of holdings in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 134.2% return, outperforming this stock by 90.5%
Profit Down
Netprofit is down for the last 2 quarters, 217.51 Cr → 45.72 Cr (in ₹), with an average decrease of 79.0% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 985.2 Cr → 833.37 Cr (in ₹), with an average decrease of 15.4% per quarter
Glaxosmithkline Pharmaceuticals Ltd in the last 5 years
Lowest (-81.64x)
December 28, 2020
Industry (62.63x)
May 3, 2024
Today (69.87x)
May 3, 2024
Highest (333.07x)
September 15, 2020
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 75% | 0.00 | |
Foreign Institutions | 3.48% | 0.00 | |
Mutual Funds | 4.51% | 0.00 | |
Retail Investors | 13.62% | 0.00 | |
Others | 3.39% | 0.00 |
Technicals of Glaxosmithkline Pharmaceuticals Ltd share
News & Events of Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) share price today is ₹2095.35
Glaxosmithkline Pharmaceuticals Ltd is listed on NSE
Glaxosmithkline Pharmaceuticals Ltd is listed on BSE
PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 69.87
PE ratio = Glaxosmithkline Pharmaceuticals Ltd Market price per share / Glaxosmithkline Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is 1.02L.
Today’s market capitalisation of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is ₹35604.91Cr.
Glaxosmithkline Pharmaceuticals Ltd(GLAXO | Price |
---|---|
52 Week High | ₹2524 |
52 Week Low | ₹1227 |
Glaxosmithkline Pharmaceuticals Ltd(GLAXO) share price is ₹2095.35. It is down -16.98% from its 52 Week High price of ₹2524
Glaxosmithkline Pharmaceuticals Ltd(GLAXO) share price is ₹2095.35. It is up 70.77% from its 52 Week Low price of ₹1227
Glaxosmithkline Pharmaceuticals Ltd(GLAXO | Returns |
---|---|
1 Day Returns | -6.4% |
1 Month Returns | 8.31% |
3 Month Returns | -14.41% |
1 Year Returns | 68.44% |